JP5324091B2 - 薬物送達のための医薬組成物及びそれを使用する症状の治療又は予防法 - Google Patents

薬物送達のための医薬組成物及びそれを使用する症状の治療又は予防法 Download PDF

Info

Publication number
JP5324091B2
JP5324091B2 JP2007518238A JP2007518238A JP5324091B2 JP 5324091 B2 JP5324091 B2 JP 5324091B2 JP 2007518238 A JP2007518238 A JP 2007518238A JP 2007518238 A JP2007518238 A JP 2007518238A JP 5324091 B2 JP5324091 B2 JP 5324091B2
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
weight
another embodiment
pharmaceutically acceptable
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2007518238A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008504272A5 (enExample
JP2008504272A (ja
Inventor
ブイ．エス．エヌ． マーシー，エラミリ
Original Assignee
アイデックス ラボラトリーズ，インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/874,552 external-priority patent/US7618651B2/en
Application filed by アイデックス ラボラトリーズ，インコーポレイティド filed Critical アイデックス ラボラトリーズ，インコーポレイティド
Publication of JP2008504272A publication Critical patent/JP2008504272A/ja
Publication of JP2008504272A5 publication Critical patent/JP2008504272A5/ja
Application granted granted Critical
Publication of JP5324091B2 publication Critical patent/JP5324091B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2007518238A 2004-06-24 2005-06-23 薬物送達のための医薬組成物及びそれを使用する症状の治療又は予防法 Expired - Lifetime JP5324091B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/874,552 2004-06-24
US10/874,552 US7618651B2 (en) 2004-06-24 2004-06-24 Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US11/019,243 US7622138B2 (en) 2004-06-24 2004-12-23 Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US11/019,243 2004-12-23
PCT/US2005/022073 WO2006012146A2 (en) 2004-06-24 2005-06-23 Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same

Publications (3)

Publication Number Publication Date
JP2008504272A JP2008504272A (ja) 2008-02-14
JP2008504272A5 JP2008504272A5 (enExample) 2012-12-13
JP5324091B2 true JP5324091B2 (ja) 2013-10-23

Family

ID=35786640

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007518238A Expired - Lifetime JP5324091B2 (ja) 2004-06-24 2005-06-23 薬物送達のための医薬組成物及びそれを使用する症状の治療又は予防法

Country Status (5)

Country Link
EP (1) EP1765293B1 (enExample)
JP (1) JP5324091B2 (enExample)
AU (1) AU2005267396B2 (enExample)
CA (1) CA2570599C (enExample)
WO (1) WO2006012146A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
HUP0700828A2 (en) * 2007-12-20 2010-01-28 Richter Gedeon Nyrt Transdermal pharmaceutical compositions containing tolperisone alone and in combination
EP2143421A1 (en) * 2008-07-07 2010-01-13 Almirall Hermal GmbH Topical composition for the treatment of actinic keratosis
SE536091C2 (sv) * 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6087215A (ja) * 1983-10-19 1985-05-16 Mitsui Toatsu Chem Inc 外用薬用基材
US4678516A (en) * 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US4843096A (en) * 1985-06-26 1989-06-27 Stiefel Laboratories, Inc. Treatment of acne
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
JP2000501388A (ja) * 1995-11-22 2000-02-08 イントラバイオティクス ファーマシューティカルズ，インコーポレーテッド． 口内粘膜症の予防および治療のための組成物および方法
US6630168B1 (en) * 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
US6238683B1 (en) * 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
IT1308187B1 (it) * 1999-02-16 2001-12-07 Formenti Farmaceutici Spa Composizioni farmaceutiche topiche a base di antiinfiammatori nonsteroidei.
JP4195178B2 (ja) * 1999-11-10 2008-12-10 東興薬品工業株式会社 消炎鎮痛外用剤
FR2802810A1 (fr) * 1999-12-23 2001-06-29 Grinda Jean Robert Nouveaux produits cosmetiques et therapeutiques a base de composes lipidiques et leur procede de preparation
JP2001245913A (ja) * 1999-12-28 2001-09-11 Lion Corp 非水系温熱ゲル組成物
TWI232758B (en) * 2000-03-21 2005-05-21 Jiun-Ren Chen High concentration vitamin C composition and method for preparing the same
WO2003094917A1 (en) * 2002-05-13 2003-11-20 Takata Seiyaku Co., Ltd. Vintoperol-containing medicinal composition for transdermal administration

Also Published As

Publication number Publication date
CA2570599C (en) 2012-03-27
WO2006012146A3 (en) 2007-02-01
EP1765293A2 (en) 2007-03-28
WO2006012146A2 (en) 2006-02-02
AU2005267396B2 (en) 2009-09-17
CA2570599A1 (en) 2006-02-02
EP1765293B1 (en) 2014-10-01
JP2008504272A (ja) 2008-02-14
EP1765293A4 (en) 2012-05-30
AU2005267396A1 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
US7622138B2 (en) Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US8361496B2 (en) Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US6669958B1 (en) Gel delivery vehicles for anticellular proliferative agents
EP0974350B1 (en) External preparation containing tranilast and process for producing the same
ES2396598T3 (es) Preparaciones en forma de suspensiones acuosas
CN1227012C (zh) 用于局部传送环加氧酶－2酶抑制剂的药物组合物
JP3526887B2 (ja) 消炎鎮痛外用貼付剤
JP2003504415A (ja) 持続放出性薬物分散剤輸送装置
US7854943B2 (en) Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US6685959B1 (en) Pharmaceutical compositions comprising 2-isoxazoles-8-aminotetralin derivatives
AU2008208151B2 (en) Topical formulation
PT1957040E (pt) Composições não aquosas de benzimidazol
JP2008504272A (ja) 薬物送達のための医薬組成物及びそれを使用する症状の治療又は予防法
EP3284484A1 (en) Transdermal preparation containing antifungal active material
WO2006103638A2 (en) Topical pharmaceutical compositions of terbinafine and processes for their preparation
WO2022003168A1 (en) Topical gel formulation containing asimadoline
JP2003160489A (ja) オンダンセトロン経皮吸収用医薬組成物
JP3538367B2 (ja) 皮膚組織障害治療・予防・改善用外用剤
US20080306132A1 (en) Novel oral compositions of carporen
CZ297199A3 (cs) Nevodný prostředek, nosič a kit pro léčení nemoci rozmnožujících se buněk

Legal Events

Date Code Title Description
A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20080620

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080620

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080728

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111004

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120104

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120112

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20120326

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120828

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20121026

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130618

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130718

R150 Certificate of patent or registration of utility model

Ref document number: 5324091

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250